Alessandra Leone

Dr. Alessandra Leone

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
CTChiara Gramegna Tota
Chiara Gramegna Tota
ALAlessandra Leone
Alessandra Leone
AKAsifa Khan
Asifa Khan
AFAntonella Forlino
Antonella Forlino
ARAntonio Rossi
Antonio Rossi
CPChiara Paganini
Chiara Paganini
Desbuquois dysplasia type 1 (DBQD1) is a recessive chondrodysplasia caused by mutations in the CANT1 gene, encoding for the Golgi Calcium-Activated Nucleotidase 1 (CANT1). The enzyme hydrolyzes UDP, the by-product of glycosyltransferase reactions, but it might play other roles in different cell types. Using a Cant1 knock-out mouse, we demonstrated that CANT1 is crucial for glycosaminoglycan (GAG) synthesis; however, its impact on the biochemical properties of cartilage proteoglycans remains unknown. Thus, in this work, we characterized decorin and aggrecan from primary chondrocyte cultures and cartilage biopsies of mutant mice at post-natal day 4 by Western blots and further investigated their distribution in the cartilage extracellular matrix (ECM) by immunohistochemistry. We demonstrated that the GAG synthesis defect caused by CANT1 impairment led to the synthesis and secretion of proteoglycans with shorter GAG chains compared with wild-type animals. However, this alteration did not result in the synthesis and secretion of decorin and aggrecan in the unglycanated form. Interestingly, the defect was not cartilage-specific since also skin decorin showed a reduced hydrodynamic size. Finally, immunohistochemical studies in epiphyseal sections of mutant mice demonstrated that the proteoglycan structural defect moderately affected decorin distribution in the ECM.

20 December 2024
Verified
Book Chapter
Closed access
PDF file
CTChiara Gramegna Tota
Chiara Gramegna Tota
ALAlessandra Leone
Alessandra Leone
CPChiara Paganini
Chiara Paganini
AKAsifa Khan
Asifa Khan
ARAntonio Rossi
Antonio Rossi
ASAndrea Superti-Furga
Andrea Superti-Furga

6 October 2026 in Proteoglycan Research
Verified
Journal Article
Open access
ALAlessandra Leone
Alessandra Leone
ZJZsuzsa Jenei-Lanzl
Zsuzsa Jenei-Lanzl
FZFrank Zaucke
Frank Zaucke
The extracellular matrix (ECM) is a dynamic and information‐rich network that integrates structural support with biochemical and mechanical signaling. Among its key regulatory components are the Small Leucine‐Rich Proteoglycans (SLRPs), a family of matrix molecules that coordinate extracellular architecture with cell signaling. Within this family, the Class I SLRPs decorin (DCN), biglycan (BGN), and asporin (ASPN) play central roles in the maintenance of musculoskeletal tissues' homeostasis. This review provides a comprehensive overview of the structural features, molecular interactions, and biological functions of DCN, BGN, and ASPN across musculoskeletal tissues in health and disease. We discuss how these SLRPs regulate collagen fibrillogenesis, extracellular matrix (ECM) assembly, and mechanotransduction while simultaneously modulating growth factor signaling pathways, particularly those involving Transforming Growth Factor‐ β (TGF‐β) and related regulators of tissue remodeling. Evidence from bone, cartilage, tendon, intervertebral disc, and skeletal muscle demonstrates their context‐dependent involvement in matrix organization and cellular responsiveness to mechanical cues. Alterations in Class I SLRPs contribute pivotally to both common and rare musculoskeletal disorders. In addition to their involvement in prevalent conditions such as osteoarthritis, osteoporosis, and tendon degeneration, dysregulation of SLRP‐mediated ECM signaling is also implicated in rare connective tissue disorders, including osteogenesis imperfecta, gerodermia osteodysplastica, musculo‐contractural Ehlers–Danlos syndrome, and biglycan‐related spondyloepimetaphyseal dysplasia. By integrating structural, mechanobiological, and signaling perspectives, this review highlights Class I SLRPs as central regulators of ECM organization and signaling in musculoskeletal tissues, providing a framework to understand their roles in musculoskeletal disorders.